Notably Indexed | Fully Open Access | Immunology Journals

We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.


Open Access at Taylor & Francis

Explore Portfolio

Looking to publish your next article?

Find the perfect home for your research. This portfolio consists of notably indexed, peer-reviewed, fully open access journals and hybrid journals, where you can choose to publish open access; aiming to serve both the academic research community and practitioner community.

The below journals have various specialties in:

  • tumor immunology
  • immunological biomarkers
  • anticancer therapies and immunotherapies
  • basic and clinical immunology
  • immunology, immunotoxicology and toxicology
  • human vaccines & immunotherapeutics
  • targets for immune based therapy and treatment protocols
  • molecular and cellular immunology

Find out if your institution or country has an open access agreement to publish with us.

Publishing open access increases the visibility and readership of your research, helping you make an impact beyond your field.
Find Out More


2019 Impact Factor 5.869
Five-Year Impact Factor 6.255

Oncoimmunology publishes international translational and clinical research into tumor immunology including anticancer therapies and immunotherapies.

Visit Journal Submit

Journal of Immunotoxicology

2019 Impact Factor 2.780
Five-Year Impact Factor 2.280

This open access journal provides a forum for the international community of immunotoxicologists, immunologists, and toxicologists working in academia, government, consulting, and industry.

Visit Journal Submit


Human Vaccines & Immunotherapeutics

2019 Impact Factor 2.619
Five-Year Impact Factor 2.716

Human Vaccines & Immunotherapeutics publishes novel and experimental vaccine research.

Visit Journal Submit


2019 Impact Factor 3.378
Five-Year Impact Factor 2.912

This journal publishes platelet and megakaryocyte related research including platelet function, pharmacology and therapeutics.

Visit Journal Submit


Ocular Immunology and Inflammation

2019 Impact Factor 2.112
Five-Year Impact Factor 2.310

This journal publishes research on diagnosis and treatment of ocular, corneal and retinal inflammation, uveitis, ophthalmology, ocular immunology and vision science.

Visit Journal Submit

Infectious Diseases

2019 Impact Factor 2.494
Five-Year Impact Factor 2.179

Infectious Diseases publishes international research on all aspects of human infections including pathogenesis, diagnosis, and treatment of infectious diseases.

Visit Journal Submit



2019 Impact Factor 2.125
Five-Year Impact Factor 2.423

This journal publishes research on immunological, immunogenetic, and autoimmune diseases like rheumatoid arthritis, Sjogren syndrome, type I diabetes and multiple sclerosis.

Visit Journal Submit

International Reviews of Immunology

2019 Impact Factor 4.580
Five-Year Impact Factor 4.062

This journal publishes articles on basic and clinical immunology, autoimmunity, inflammatory and allergic diseases, vaccines and other relevant aspects of immunology.

Visit Journal Submit


Immunological Investigations

2019 Impact Factor 2.511
Five-Year Impact Factor 2.337

The journal publishes research in molecular and cellular immunology, focusing on all aspects of fundamental and applied immunology

Visit Journal Submit

Questions about the publishing process?

Visit our dedicated and ever-expanding site for authors, Author Services, to find out more about how to get published and your publishing options.
Find Out More


F1000Research is an Open Research publishing platform for scientists, scholars and clinicians, supporting data deposition and sharing. Publish all your findings including null results, data notes and more.
Go To F1000Research
Dove Medical Press is part of the Taylor & Francis Group, specializing in the publication of Open Access peer-reviewed journals across the broad spectrum of science, technology and especially medicine.
Go To Dove Press

Latest tweets from @tandfmedicine